EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34+ Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34+ Cells
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 2, Pages 319
Publisher
MDPI AG
Online
2021-01-18
DOI
10.3390/cancers13020319
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Pleiotropic Role and Bidirectional Immunomodulation of Innate Lymphoid Cells in Cancer
- (2020) Zhengwen An et al. Frontiers in Immunology
- The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation
- (2020) Sylvie Taveirne et al. BLOOD
- Targeted Therapies: Friends or Foes for Patient’s NK Cell-Mediated Tumor Immune-Surveillance?
- (2020) Laura Damele et al. Cancers
- EZH2 inhibition: a promising strategy to prevent cancer immune editing
- (2020) Ning Kang et al. Epigenomics
- ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22/AKT signaling
- (2019) X. Xuan et al. Clinical & Translational Oncology
- Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
- (2019) Daniela Pende et al. Frontiers in Immunology
- An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More
- (2019) Massimo Vitale et al. Frontiers in Immunology
- Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
- (2019) Ziqing Chen et al. Cancers
- Phase 1 study of the novel enhancer of zeste homolog 2 (EZH2) inhibitor GSK2816126 in patients with advanced hematological and solid tumors
- (2019) Timothy A. Yap et al. CLINICAL CANCER RESEARCH
- Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas
- (2019) Makoto Yamagishi et al. Cell Reports
- Interleukin-7 Receptor Alpha in Innate Lymphoid Cells: More Than a Marker
- (2019) Abdalla Sheikh et al. Frontiers in Immunology
- Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
- (2018) Antoine Italiano et al. LANCET ONCOLOGY
- IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients
- (2018) Ana Vuletić et al. PATHOLOGY & ONCOLOGY RESEARCH
- Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells
- (2018) Suresh Bugide et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overcoming immune suppression with epigenetic modification in ovarian cancer
- (2018) Tyler R. McCaw et al. Translational Research
- Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor
- (2018) Shiyang Li et al. Frontiers in Immunology
- Human AML activates the AHR pathway to impair NK cell development and function
- (2018) Steven D. Scoville et al. BLOOD
- Innate Lymphoid Cells: 10 Years On
- (2018) Eric Vivier et al. CELL
- Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
- (2018) Sangeeta Goswami et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
- (2018) Nayoung Kim et al. Frontiers in Immunology
- IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses
- (2018) Rosa M. Santana Carrero et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function
- (2018) Laura Damele et al. Frontiers in Immunology
- Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types
- (2017) Vincent van Unen et al. Nature Communications
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
- (2017) Anne-Sophie Chretien et al. Frontiers in Immunology
- Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells
- (2017) Steven D. Scoville et al. Frontiers in Immunology
- Epigenomic Views of Innate Lymphoid Cells
- (2017) Giuseppe Sciumè et al. Frontiers in Immunology
- Indicators of responsiveness to immune checkpoint inhibitors
- (2017) Bradley D. Shields et al. Scientific Reports
- Combining Epigenetic and Immunotherapy to Combat Cancer
- (2016) Katherine B. Chiappinelli et al. CANCER RESEARCH
- Developmental Acquisition of Regulomes Underlies Innate Lymphoid Cell Functionality
- (2016) Han-Yu Shih et al. CELL
- The Basis of Oncoimmunology
- (2016) A. Karolina Palucka et al. CELL
- Human innate lymphoid cells
- (2016) Elisa Montaldo et al. IMMUNOLOGY LETTERS
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- NKp80 Defines a Critical Step during Human Natural Killer Cell Development
- (2016) Aharon G. Freud et al. Cell Reports
- Epigenetics in Cancer: A Hematological Perspective
- (2016) Maximilian Stahl et al. PLoS Genetics
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
- (2016) Claudia Cantoni et al. Journal of Immunology Research
- Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias
- (2015) Gabriella Pietra et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities
- (2015) Koen Schepers et al. Cell Stem Cell
- Epigenetic regulation in human melanoma: past and future
- (2015) Debina Sarkar et al. Epigenetics
- The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro
- (2015) Jochen Vasold et al. LEUKEMIA RESEARCH
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
- (2015) Ende Zhao et al. NATURE IMMUNOLOGY
- Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
- (2015) Jie Yin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures
- (2015) Paolo Carrega et al. Nature Communications
- Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment
- (2015) Monica Parodi et al. OncoImmunology
- IL-1 -releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from CD34+ precursors
- (2014) C. Vitale et al. HAEMATOLOGICA
- Human RORγt+CD34+ Cells Are Lineage-Specified Progenitors of Group 3 RORγt+ Innate Lymphoid Cells
- (2014) Elisa Montaldo et al. IMMUNITY
- CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
- (2014) P. Carrega et al. JOURNAL OF IMMUNOLOGY
- Development of human natural killer cells and other innate lymphoid cells
- (2014) Elisa Montaldo et al. SEMINARS IN IMMUNOLOGY
- The Transcription Factor AHR Prevents the Differentiation of a Stage 3 Innate Lymphoid Cell Subset to Natural Killer Cells
- (2014) Tiffany Hughes et al. Cell Reports
- Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
- (2014) Lorenzo Moretta et al. Frontiers in Immunology
- EZH2 in normal and malignant hematopoiesis
- (2013) K Lund et al. LEUKEMIA
- Location and cellular stages of natural killer cell development
- (2013) Jianhua Yu et al. TRENDS IN IMMUNOLOGY
- Epigenetic regulation of NK cell differentiation and effector functions
- (2013) Frank Cichocki et al. Frontiers in Immunology
- Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
- (2012) G. Pietra et al. CANCER RESEARCH
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Natural killer cell distribution and trafficking in human tissues
- (2012) Paolo Carrega et al. Frontiers in Immunology
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- Natural killer cells kill human melanoma cells with characteristics of cancer stem cells
- (2009) G. Pietra et al. INTERNATIONAL IMMUNOLOGY
- Dendritic Cell Interactions with NK Cells from Different Tissues
- (2009) Guido Ferlazzo et al. JOURNAL OF CLINICAL IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started